SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001047469-99-038767
Filing Date
1999-10-14
Accepted
1999-10-14 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 13G SC 13G 16583
  Complete submission text file 0001047469-99-038767.txt   18637
Mailing Address 148 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 333 PROVIDENCE HIGHWAY NORWOOD MA 02062 6176619312
IMMUNOGEN INC (Subject) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-40774 | Film No.: 99728079
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice